Active BMN 111: Subcutaneous injection of recommended dose of BMN 111 based on weight-band dosing once daily.
111-208
Phase 2 small_molecule active
Quick answer
Active BMN 111: Subcutaneous injection of recommended dose of BMN 111 based on weight-band dosing once daily. for Achondroplasia is a Phase 2 program (small_molecule) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOMARIN PHARMACEUTICAL INC
- Indication
- Achondroplasia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active